Z-360, a novel therapeutic agent for pancreatic cancer, prevents up-regulation of ephrin B1 gene expression and phosphorylation of NR2B via suppression of interleukin-1 β production in a cancer-induced pain model in mice (Q39639268)
Jump to navigation
Jump to search
scientific article published on October 28, 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Z-360, a novel therapeutic agent for pancreatic cancer, prevents up-regulation of ephrin B1 gene expression and phosphorylation of NR2B via suppression of interleukin-1 β production in a cancer-induced pain model in mice |
scientific article published on October 28, 2010 |
Statements
1 reference
Z-360, a novel therapeutic agent for pancreatic cancer, prevents up-regulation of ephrin B1 gene expression and phosphorylation of NR2B via suppression of interleukin-1 β production in a cancer-induced pain model in mice (English)
1 reference
Yuki Orikawa
1 reference
Hiroki Kato
1 reference
Koichi Seto
1 reference
Nobuyoshi Kobayashi
1 reference
Koji Yoshinaga
1 reference
Hiroki Hamano
1 reference
Yuko Hori
1 reference
Tim Meyer
1 reference
Mineo Takei
1 reference
28 October 2010
1 reference
1 reference
6
1 reference
72
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference